Tracer library / [211At]At-(RGD)4

[211At]At-(RGD)4

Also written as [211At]At-(RGD)4
Radionuclide
At-211
Modality
—
Production route
—
Stage
Preclinical
Syntheses indexed
0
Preclinical only, no clinical indication yetReceptor expression phenotypingOther radioligand therapy

What it is

Compound class
Tetravalent RGD peptide
Target / mechanism
Integrin αvβ3 PMID 40083181
Clinical application
Integrin αvβ3-targeted radionuclide therapy PMID 40083181
Theranostic pair
—

Published syntheses

No synthesis has been parsed for this agent yet.

Need this precursor?We can point you to suppliers for [211At]At-(RGD)4, or handle the enquiry for you.

Get in touch

Notes

Added at stage 39 (2026-09-27) from a reverse search of the PubMed corpus's own unattached articles (articles that named a real compound not yet in this reference): 2 article(s) found under this name, not yet individually researched. Target/mechanism, clinical application, indications, approval, modality, stage and production route are intentionally left empty. PMIDs: 40083181, 42574781. Stage set/updated at stage 39 from PMID 40083181: 'Finally, 211At-(RGD)4 was synthesized with >95% radiochemical purity and exhibited an almost identical biodistribution pattern to 125I-(RGD)4.'.